Dr. Rachel Holden
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate (NCT02672293) | Dr. Rachel Holden | 2013-01-01 |
| Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients (NCT01528800) | Dr. Rachel Holden | 2012-11-01 |
Track Dr. Rachel Holden automatically
Every clearance here is in the API, with alerts when new ones post.